| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1016/J.EJCA.2013.10.004 |
| P8608 | Fatcat ID | release_iffnc6fyjvaalpwheg73k4rc2m |
| P698 | PubMed publication ID | 24269135 |
| P50 | author | Giuseppe Curigliano | Q47736732 |
| Elisabetta Munzone | Q56850295 | ||
| Aron Goldhirsch | Q87121329 | ||
| P2093 | author name string | Giancarlo Pruneri | |
| Franco Nolè | |||
| Giuseppe Viale | |||
| Vincenzo Bagnardi | |||
| Laura Adamoli | |||
| Davide Disalvatore | |||
| Angela Sciandivasci | |||
| Gaetano Aurilio | |||
| Fernando De Vita | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| Erb-b2 receptor tyrosine kinase 2 | Q415271 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 277-289 | |
| P577 | publication date | 2013-11-21 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases | |
| P478 | volume | 50 |
| Q37662685 | 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. |
| Q54968815 | A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer. |
| Q39336765 | A study of tumor heterogeneity in a case with breast cancer |
| Q27343148 | AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015. |
| Q90608888 | An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube |
| Q65000145 | Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry. |
| Q54096708 | Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer. |
| Q53509601 | Benefits of using the cell block method to determine the discordance of the HR/HER2 expression in patients with metastatic breast cancer. |
| Q35873283 | Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy |
| Q36239768 | Biopsy of breast cancer metastases: patient characteristics and survival |
| Q93069607 | Breast Carcinoma Metastasis to the Medial Rectus Muscle: Case Report |
| Q90241672 | Breast cancer |
| Q49796316 | Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. |
| Q38887777 | Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital |
| Q33702526 | Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography? |
| Q43378663 | Cat Mammary Tumors: Genetic Models for the Human Counterpart |
| Q38431284 | Clinical management of breast cancer heterogeneity |
| Q53277939 | Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinoma. |
| Q92204333 | Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study |
| Q36847104 | Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis |
| Q41932946 | Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation |
| Q34834419 | Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis |
| Q54322784 | Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients. |
| Q47870184 | Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. |
| Q41716164 | Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer |
| Q52668202 | Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers. |
| Q53633720 | Epigenetic variations in breast cancer progression to lymph node metastasis. |
| Q89605812 | Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival |
| Q38842674 | Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review |
| Q90471489 | Evaluations of Biomarker Status Changes between Primary and Recurrent Tumor Tissue Samples in Breast Cancer Patients |
| Q57793316 | Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer |
| Q55178493 | Gastric metastasis from invasive lobular breast cancer, mimicking primary gastric cancer: A case report. |
| Q26780318 | HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach |
| Q35538755 | HER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis |
| Q40419939 | HER2 mRNA transcript quantitation in breast cancer |
| Q97532154 | Hdc-expressing myeloid-derived suppressor cells promote basal-like transition and metastasis of breast cancer |
| Q64965659 | Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating? |
| Q64094297 | Hormone Receptors and Human Epidermal Growth Factor (HER2) Expression in Fine-Needle Aspirates from Metastatic Breast Carcinoma - Role in Patient Management |
| Q64093580 | Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases |
| Q92920230 | Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients |
| Q33841547 | Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT. |
| Q51716428 | Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours. |
| Q92433344 | Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer |
| Q37653376 | Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature |
| Q36510875 | Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT. |
| Q38810954 | Molecular Concordance Between Primary Breast Cancer and Matched Metastases. |
| Q41233528 | Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy |
| Q38756841 | Molecular pathology in real time |
| Q37398787 | Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis. |
| Q39011826 | One microenvironment does not fit all: heterogeneity beyond cancer cells |
| Q36266131 | Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes. |
| Q33736383 | Preparation and Identification of HER2 Radioactive Ligands and Imaging Study of Breast Cancer-Bearing Nude Mice |
| Q64243735 | Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution? |
| Q35427994 | Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer |
| Q28079224 | Progress in the clinical detection of heterogeneity in breast cancer |
| Q50120368 | Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis |
| Q97070217 | Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution |
| Q36545690 | Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing |
| Q37690662 | Review: Receptor Targeted Nuclear Imaging of Breast Cancer. |
| Q52990348 | Seeding after ultrasound-guided percutaneous biopsy of liver metastases in patients with colorectal or breast cancer. |
| Q36069770 | Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients |
| Q38859024 | Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer. |
| Q40409180 | St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study. |
| Q37500001 | Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions |
| Q39390640 | Targeting the mTOR pathway in breast cancer |
| Q89883669 | The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients |
| Q36736096 | Transcriptome profile of the early stages of breast cancer tumoral spheroids |
Search more.